Skip to Content

Clinical Trials
Patient Portal

Loading component...

Loading component...

A Phase II, Multicenter, Prospective Study of Sacituzumab Govitecan in Recurrent Glioblastoma

Phase: Clinical Trial
Trial Number: 04559230
Trial Status: OPEN

Study Overview

Learn More About This Study

Participating Locations

‌

‌
‌

‌
‌

About Us
Specialities & Services
Request Appointment
Careers
Contact Us
Media Center
Cancer Support Services
Careopolis
Important Notifications

Find a Provider
Find a Location
Clinical Trials
Patient Portal
Patient Forms
Patient Resources
Patient Rights & Privacy
Insurance Information

© 2026 Texas Oncology. All rights reserved.|Privacy Notice|Terms of Use